Braze (NASDAQ:BRZE) Rating Reiterated by JMP Securities

Braze (NASDAQ:BRZE – Get Free Report)‘s stock had its “market outperform” rating restated by stock analysts at JMP Securities in a report issued on Tuesday, Benzinga reports. They presently have a $68.00 price objective on the stock. JMP Securities’ target price suggests a potential upside of 110.14% from the company’s current price. Several other brokerages […]

Leave a Reply

Your email address will not be published.

Previous post Cibus (NASDAQ:CBUS) Price Target Lowered to $23.50 at Alliance Global Partners
Next post StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)